Liquid Biopsies and Minimally-Invasive Diagnostics 2017

Date: Thursday, 5 October 2017 - Friday, 6 October 2017
Location: Coronado Island, California

Keynote Speakers

Hsian-Rong Tseng
Professor, Crump Institute for Molecular Imaging, California NanoSystems Institute, University of California-Los Angeles

Janet Jin
Director of Assay Development, Roche Sequencing Solutions

Yoon-Kyoung Cho
Professor, Biomedical Engineering, Ulsan National Institute of Science & Technology; Group leader, IBS; FRSC, Fellow of Royal Society of Chemistry

Fred Kramer
Professor, New Jersey Medical School Rutgers University

Jan Lötvall
Professor, University of Gothenburg; Founding President of ISEV; Editor-in-Chief, Journal of Extracellular Vesicles

John Sninsky
Chief Scientific Officer, CareDx

Allison Ballmer International Business Leader, Roche Molecular Systems, Inc.	Sehyun Shin Professor & Director, Nano-Biofluignostic Engineering Research Center, Korea University and Anam/Guro Hospital of Korea University	Utkan Demirci Professor, Stanford University School of Medicine	Dominique PV de Kleijn Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands	Shana Kelley Professor, University of Toronto	Ellen Beasley Senior Vice President, Genomic Health Inc
David Wong Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles	Steve Soper Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas	Chamindie Punyadeera Associate Professor, Institute of Health and Biomedical Innovation, Queensland University of Technology	Michael Heller Professor, Dept Bioengineering, University of California-San Diego

Overview

Select Biosciences Fourth Annual Liquid Biopsies and Minimally-Invasive Diagnostics 2017 Conference brings together academic researchers, industry researchers, as well as biotechnology and pharmaceutical companies to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as other disease classes.

Slide Deck Downloads:

Liquid Biopsy Slide Deck

Exosomes Market Dynamics

This Liquid Biopsies Conference focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers. There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.

The conference further explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for patient monitoring.

This conference is held concurrently with the NGS, RNA-Seq, Single Cell Analysis & Single Molecule Analysis: Research to Diagnostics 2017 Conference enabling delegates full access to the presentations, co-located exhibit hall and extensive networking opportunities.

Agenda Topics

Circulating Tumor Cells (CTCs): Potential for Development of Liquid Biopsies
Circulating Tumor DNA (ctDNA): Potential for Development of Liquid Biopsies

Emerging Technologies and Emerging Companies Showcase
Technology Platforms for Interrogation

Extracellular Nucleic Acids in the Circulation: Circulating Free DNA, Extracellular RNAs and Circulating microRNAs/Long Non-Coding RNAs
Extracellular Vesicles (EVs) and Exosomes: Potential for Development of Liquid Biopsies
US vs. EU vs. Asia/Pacific Regulatory Landscape for Liquid Biopsies

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Larry Blocher, Chief Executive Officer, Bio-Options, Inc.
Steven Gross, Head of CellSearch Assay Development, Menarini Silicon Biosystems, Inc.
Taylor Jensen, Director, Research and Development, Sequenom (a LabCorp Company)
Robert Kinders, Sr. Principal Scientist and Head, Laboratory of Human Toxicology and Pharmacology, Frederick National Laboratory for Cancer Research
Balaji Panchapakesan, Professor, Department of Mechanical Engineering, Worcester Polytechnic Institute (WPI)
Ian Papautsky, Richard and Loan Hill Professor of Bioengineering, Co-Director, NSF Center for Advanced Design & Manufacturing of Integrated Microfluidics, University of Illinois at Chicago
Arturo Ramirez, Senior Scientist, RareCyte, Inc.
Shivani Sharma, Associate Director, California NanoSystems Institute, California NanoSystems Institute, UCLA
AmirAli Talasaz, Co-Founder, President & COO, Guardant Health
Kai Wang, Principal Scientist, Institute for Systems Biology
William Whitford, Strategic Solutions Leader, GE Healthcare

Corporate Sponsors	Media Sponsors	Official Journal Partner	Networking

Add to Calendar ▼2017-10-05 00:00:002017-10-06 00:00:00Europe/LondonLiquid Biopsies and Minimally-Invasive Diagnostics 2017Liquid Biopsies and Minimally-Invasive Diagnostics 2017 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors